Krystal Biotech (NasdaqGS:KRYS) Update / Briefing Transcript

Krystal Biotech (NasdaqGS:KRYS) Update / Briefing January 08, 2026 04:30 PM ET Company ParticipantsKrish Krishnan - CEODavid Sweet - Director of Clinical DevelopmentJorge Lascano - Professor of MedicineSuma Krishnan - President of Research and DevelopmentTrevor Parry - VP of Product DevelopmentConference Call ParticipantsGautam Chukka - Research AnalystJoe Pantginis - Director of Research and Senior Healthcare AnalystRitu Baral - Managing Director and Senior Biotechnology AnalystRoger Song - Senior AnalystA ...